-+ 0.00%
-+ 0.00%
-+ 0.00%

Innate Pharma completes corporate reorganization, implements layoffs under job protection plan

PUBT·05/13/2026 05:05:45
Listen to the news
Innate Pharma completes corporate reorganization, implements layoffs under job protection plan
  • Innate Pharma completed a corporate reorganization, implementing planned job cuts under an employment protection plan that has now concluded.
  • Reorganization aligned with strategic priorities as company advanced key clinical programs, including plans to start Phase 3 TELLOMAK-3 in H2 2026.
  • Cash, cash equivalents, and financial assets totaled EUR 25.4 million at March 31, 2026, with total financial liabilities of EUR 20.3 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Innate Pharma SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20260512339761) on May 13, 2026, and is solely responsible for the information contained therein.